Keyphrases
Receptor-mediated
100%
Tumor Necrosis Factor-α
100%
Antibody-mediated
100%
Arthritis Patients
100%
Foxp3 Expression
100%
Differential Effects
100%
Decoy Receptor
100%
Blockage
100%
Etanercept
75%
Rheumatoid Arthritis Patients
75%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
50%
Anti-tumor Necrosis Factor Antibody
50%
Lymphotoxin
50%
CD4+ T Cells
50%
Forkhead Box P3 (FOXP3)
50%
Anti-tumor Necrosis Factor Therapy
50%
Prospective Cohort Study
25%
Quantitative PCR
25%
Splice Forms
25%
Healthy Controls
25%
Clinical Improvement
25%
Fusion Protein
25%
Infliximab
25%
Disease Activity Score 28 (DAS28)
25%
TNF Receptor 2 (TNFR2)
25%
Clinical Change
25%
CD25
25%
MRNA Expression
25%
Adalimumab
25%
Antibody Therapy
25%
Immunology and Microbiology
Tumor Necrosis Factor Alpha
100%
Arthritis
100%
Etanercept
42%
Inflammatory Arthritis
42%
Lymphotoxin
28%
Tumor Necrosis Factor Antibody
28%
T-Helper Cell
28%
CTLA-4
28%
Infliximab
14%
Adalimumab
14%
CD25
14%
Real-Time Polymerase Chain Reaction
14%
Tumor Necrosis Factor Receptor 2
14%